PT
Therapeutic Areas
Diasome Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OPTI-2, Injectable HDV-Rapid Acting Insulin | Type 1 Diabetes | Phase 2B |
| Injectable HDV-Rapid Acting Insulin (Open Label, MoA) | Diabetes | Phase 2 |
| Injectable HDV-GLP-1, Novel Mechanism | Metabolic Disease/Obesity | Preclinical |
| Oral HDV-Serotonin, Novel Mechanism | Insulin Resistance/Metabolic Disease | Preclinical |